Can nitric oxide-generating compounds improve the oxidative stress response in experimentally diabetic rats?

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 7, 2007, Pages 586-593

  Mohamadin, Ahmed M A ^a,d   Hammad, Lamiaa Na ^a   El Bab, Mohamed Fath ^b   Gawad, Hala S Abdel ^c  

^a AL AZHAR UNIVERSITY   (Egypt)

^b Suez Canal University   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Free radicals; Nitric oxide donors; Oxidative stress; Streptozotocin

Indexed keywords

ANTIOXIDANT; ARGININE; BIOLOGICAL MARKER; CATALASE; CHOLESTEROL; ENZYME; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BIOSYNTHESIS; BLOOD SAMPLING; BULIMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DECAPITATION; DIABETES MELLITUS; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL RAT; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY HOMOGENATE; LINEAR REGRESSION ANALYSIS; LIPID PEROXIDATION; LIVER HOMOGENATE; MALE; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; POLYDIPSIA; PROTECTION; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; ARGININE; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; KIDNEY; LINEAR MODELS; LIPID PEROXIDATION; LIPIDS; LIVER; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 34250789578     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04622.x     Document Type: Article

References (60)

1. Baynes YW, Thorpe R. Role of oxidative stress in diabetic complications. Diabetes 1999 48 : 1 9.
2. Bucala R, Cerami A. Advanced glycosylation: Chemistry, biology and implications for diabetes and aging. Adv. Pharmacol. 1992 23 : 1 34.
3. Ganz MB, Seftel A. Glucose induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am. J. Physiol. Endocrinol. Metab. 2000 278 : E146 52.
4. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003 17 : 24 38.
5. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 2000 130 : 963 74.
6. Halliwell B, Gulteridge J. Free Radicals in Biology and Medicine, 3rd edn. Clarendon Press, Oxford. 1999 103 19.
7. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N. Engl. J. Med. 1984 310 : 341 6.
8. Obrosova I, Fathallah L, Liu E, Nourooz-Zadeh J. Early oxidative stress in diabetic kidney: Effect of dl-alpha lipoic acid. Free Radic. Biol. Med. 2003 34 : 186 95.
9. Yue K, Chung W, Leung A, Cheng C. Redox changes precede the occurrence of oxidative stress in eyes and aorta, but not in kidneys of diabetic rats. Life Sci. 2003 73 : 2557 70.
10. Bohr V, Raghuram N, Sivakami S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin induced diabetic rats. Int. J. Biochem. Cell Biol. 2004 36 : 89 97.
11. Dincer Y, Akcay T, Alademir Z, Ilkova H. Effects of oxidative stress on glutathione pathways in red blood cells from patients with dependent diabetes mellitus. Metabolism 2002 51 : 1360 2.
12. Ferllet-Coudray C, Rock E, Coudray C, Grzelkowska K, Azais-Braesco V, Dardevet D. Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chim. Acta 1999 284 : 31 43.
13. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: The guanylate cyclase-cyclic GMP system. J. Cardiovasc. Pharmacol. 1988 12 (Suppl. S115 18.
14. Cohen GA, Hobbs AJ, Fitch RM, Zinner MJ, Ignarro LJ. Nitric oxide regulates endothelium-dependent vasodilator responses in rabbit hindquarters vascular bed in vivo. Am. J. Physiol. 1996 271 : H133 9.
15. Joshi M, Ponthier J, Lancaster J. Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic. Biol. Med. 1999 27 : 1357 66.
16. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl Acad. Sci. USA 2004 101 : 4003 8.
17. O'Donnell VB, Chumley PH, Hogg N, Bloodsworth A, Darley-Usmar VM, Freeman BA. Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction with lipid peroxyl radicals and comparison with α-tocopherol. Biochemistry 1997 36 : 15 216 23.
18. Willmot M, Gray L, Gibson C, Murphy S, Bath PMW. A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 2005 12 : 141 9.
19. Butler AR, Glidewell C. Recent chemical studies of sodium nitroprusside relevant to its hypotensive action. Chem. Soc. Rev. 1987 16 : 361 80.
20. Andoh TF, Gardner MP, Bennett WM. Protective effects of dietary l-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 1997 64 : 1236 40.
21. Secilmis MA, Karatas Y, Yorulmaz O et al. Protective effect of l-arginine intake on the impaired renal vascular responses in the gentamicin-treated rats. Nephrol. Physiol. 2005 100 : 13 20.
22. Rahman A, Ahmed S, Khan N, Sultana S, Athar M. Glyceryl trinitrate, a nitric oxide donor, suppresses renal oxidant damage caused by potassium bromate. Redox Rep. 1999 4 : 263 9.
23. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur. J. Pharmacol. 2005 511 : 53 64.
24. Ivorra MD, Paya M, Villar A. Hypoglycemic and insulin release effects of tormentic acid: A new hypoglycemic natural products. Planta Med. 1988 54 : 282 6.
25. Aksoy N, Vural H, Sabuncu T, Aksoy S. Effect of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats. Cell Biochem. Funct. 2003 21 : 121 5.
26. Damasceno DC, Volpato GT, Paranhos-Calderon M, Cunha-Rudge MV. Oxidative stress and diabetes in pregnant rats. Anim. Reprod. Sci. 2002 15 : 235 44.
27. Kedziora K, Szram S, Komotowski T, Szadujkis-Szaduriki L, Bartosz G. The effect of verapamil on the antioxidants defense system in diabetic kidney. Clin. Chim. Acta 2002 322 : 105 12.
28. Siddique O, Sun Y, Lin JC, Chien YW. Facilitated transdermal transport of insulin. J. Pharm. Sci. 1989 76 : 341 5.
29. Anaya-Prado R, Toledo-Pereyra LH, Reuben J, Ward PA. Exogenous nitric oxide donor and related compounds protect against lung inflammatory response after hemorrhagic shock and resuscitation. J. Trauma 2004 57 : 980 8.
30. Winterbourn CC. Oxidative reactions of hemoglobin. Methods Enzymol. 1990 186 : 265 72.
31. Uchiyama M, Mihara M. Determination of malondialdehyde precursors in tissues by thiobarbituric acid test. Anal. Biochem. 1978 86 : 271 8.
32. Ellman G. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959 82 : 70 7.
33. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 1976 71 : 952 8.
34. Aebi H. Catalase. In : Bergmeyer HU (ed.). Methods in Enzymatic Analysis, Vol. 3. Academic Press, New York. 1983 276 86.
35. Marklund S, Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and convenient assay for superoxide dismutase. Eur. J. Biochem. 1974 47 : 469 74.
36. Moshage H, Kok B, Huizenga J, Jansen P. Nitrate and nitrite determination in plasma: A critical evaluation. Clin. Chem. 1995 41 : 892 6.
37. Lowry OH, Rosenbrough NJ, Farr AL, Randall R. Protein determination using Folin-Cicocalteu reagent. J. Biol. Chem. 1951 193 : 265 78.
38. Wild S, Roglic G, Green A, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 53.
39. Virkamaki A, Ueki K, Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 1999 103 : 931 43.
40. Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuno J. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease. Am. J. Nephrol. 1991 11 : 37 43.
41. Jain SK, Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic. Biol. Med. 1997 22 : 593 6.
42. Bunn HG, Gabby KH, Gallop PM. The glycosylation of hemoglobin: Relevance to diabetes mellitus. Science 1978 200 : 21 7.
43. Lander HM, Sehajpal P, Levine DM, Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 1993 150 : 1509 16.
44. Mendez JD, Balderas F. Regulation of hyperglycemia and dyslipidemia by exogenous l-arginine in diabetic rats. Biochimie 2001 83 : 453 8.
45. El-Missiry MA, Othman AI, Amer MA. l-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J. Appl. Toxicol. 2004 24 : 93 7.
46. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB. Effect of D-400, a herbomineral preparation on lipid profile, glycated hemoglobin and glucose tolerance in streptozotocin induced diabetes in rats. Indian J. Exp. Biol. 1995 33 : 798 800.
47. Al-Shamaony L, Al-Khazraji SM, Twaij HAA. Hypoglycemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharmacol. 1994 43 : 167 71.
48. Boger RH, Bodge-Boger SM, Brandes RP et al. Dietary l-arginine reduces the progression of atherosclerosis in cholestroled-fed rabbits. Comparison with lovastatin. Circulation 1997 94 : 1282 90.
49. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem. Funct. 2003 21 : 291 6.
50. Murakami K, Kondo T, Ohtsuda Y, Fujiwara Y, Shimada M, Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 1989 38 : 753 8.
51. Anathan R, Basker C, Narmatha V, Pani L, Ramkumas K. Antidiabetic effect of Gymnema montanum leaves: Effect on lipid peroxidation induced oxidative stress in experimental diabetes. J. Pharmacol. Res. 2003 48 : 551 6.
52. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 1999 13 : 23 30.
53. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation. Biochemical, biologic and clinical implications for diabetes and aging. Lab. Invest. 1994 70 : 138 51.
54. Méndez JD, Balderas FL. Inhibition by l-arginine and spermidine of hemoglobin glycation and lipid peroxidation in rats with induced diabetes. Biomed. Pharmacother. 2005 60 : 26 31.
55. Yan H, Harding JJ. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem. J. 1997 328 : 599 605.
56. Santhakumari P, Prakasam A, Pugalendi KV. Modulation of oxidative stress parameters by treatment with Piper betel leaf in streptozotocin induced diabetic rats. Indian J. Pharmacol. 2003 35 : 373 8.
57. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J. Clin. Invest. 2000 105 : 1631 9.
58. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hypertension 1998 31 : 1047 60.
59. Krishna Mohan I, Das UN. Effect of l-arginine-nitric oxide system on the metabolism of essential fatty acids in chemical-induced diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 2000 62 : 35 46.
60. Wedgwood S, McMullan M, Bekker J, Fineman J, Black S. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ. Res. 2000 89 : 357 64.